599 related articles for article (PubMed ID: 31210717)
1. Management of betablocked patients after sustained virological response in hepatitis C cirrhosis.
Abadía M; Montes ML; Ponce D; Froilán C; Romero M; Poza J; Hernández T; Fernández-Martos R; Olveira A;
World J Gastroenterol; 2019 Jun; 25(21):2665-2674. PubMed ID: 31210717
[TBL] [Abstract][Full Text] [Related]
2. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
[TBL] [Abstract][Full Text] [Related]
3. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension.
Lens S; Baiges A; Alvarado-Tapias E; LLop E; Martinez J; Fortea JI; Ibáñez-Samaniego L; Mariño Z; Rodríguez-Tajes S; Gallego A; Bañares R; Puente Á; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; García-Pagán JC; Forns X
J Hepatol; 2020 Dec; 73(6):1415-1424. PubMed ID: 32535060
[TBL] [Abstract][Full Text] [Related]
5. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
[TBL] [Abstract][Full Text] [Related]
6. Variceal recurrence 4 years post endoscopic band ligation in hepatitis C patients who achieved sustained virological response with oral direct-acting antiviral therapy.
Ibrahim ES; Abdel-Samiee M; Youssef MI; El-Shazly H; A El-Gendy AE; Sakr AA; Elwazzan D; Nassar MR; Aly Elshormilisy A; Madkour A; Kamal M; Amrousy YM; Elkhadry SW; Abdelsameea E
J Viral Hepat; 2021 Feb; 28(2):279-287. PubMed ID: 33098209
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic prevention of variceal bleeding and rebleeding.
Baiges A; Hernández-Gea V; Bosch J
Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.
Kim HY; So YH; Kim W; Ahn DW; Jung YJ; Woo H; Kim D; Kim MY; Baik SK
J Hepatol; 2019 Mar; 70(3):412-422. PubMed ID: 30389550
[TBL] [Abstract][Full Text] [Related]
9. Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis.
Kotani K; Enomoto M; Uchida-Kobayashi S; Tamori A; Yukawa-Muto Y; Odagiri N; Motoyama H; Kozuka R; Kawamura E; Hagihara A; Fujii H; Kageyama K; Yamamoto A; Yoshida A; Higashiyama S; Kawabe J; Kawada N
J Gastroenterol; 2023 Apr; 58(4):394-404. PubMed ID: 36729172
[TBL] [Abstract][Full Text] [Related]
10. Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients.
Puigvehí M; Londoño MC; Torras X; Lorente S; Vergara M; Morillas RM; Masnou H; Serrano T; Miquel M; Gallego A; Lens S; Carrión JA
J Gastroenterol; 2020 Feb; 55(2):205-216. PubMed ID: 31493238
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
12. Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.
Silkauskaite V; Pranculis A; Mitraite D; Jonaitis L; Petrenkiene V; Kupcinskas L
Medicina (Kaunas); 2009; 45(1):8-13. PubMed ID: 19223700
[TBL] [Abstract][Full Text] [Related]
13. Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis.
Lens S; Alvarado-Tapias E; Mariño Z; Londoño MC; LLop E; Martinez J; Fortea JI; Ibañez L; Ariza X; Baiges A; Gallego A; Bañares R; Puente A; Albillos A; Calleja JL; Torras X; Hernández-Gea V; Bosch J; Villanueva C; Forns X; García-Pagán JC
Gastroenterology; 2017 Nov; 153(5):1273-1283.e1. PubMed ID: 28734831
[TBL] [Abstract][Full Text] [Related]
14. Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices.
Sharma P; Kumar A; Sharma BC; Sarin SK
Aliment Pharmacol Ther; 2009 Jul; 30(1):48-60. PubMed ID: 19392862
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Gralnek IM; Camus Duboc M; Garcia-Pagan JC; Fuccio L; Karstensen JG; Hucl T; Jovanovic I; Awadie H; Hernandez-Gea V; Tantau M; Ebigbo A; Ibrahim M; Vlachogiannakos J; Burgmans MC; Rosasco R; Triantafyllou K
Endoscopy; 2022 Nov; 54(11):1094-1120. PubMed ID: 36174643
[TBL] [Abstract][Full Text] [Related]
16. Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals.
Noureddin M; Wong MM; Todo T; Lu SC; Sanyal AJ; Mena EA
World J Gastroenterol; 2018 Mar; 24(11):1269-1277. PubMed ID: 29568207
[TBL] [Abstract][Full Text] [Related]
17. Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices.
Zacharias AP; Jeyaraj R; Hobolth L; Bendtsen F; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011510. PubMed ID: 30372514
[TBL] [Abstract][Full Text] [Related]
18. RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
Calvaruso V; Celsa C; D'Ambrosio R; Simone F; Petta S; Cacciola I; Enea M; Battaglia S; Pandolfo A; Licata M; Degasperi E; Cabibbo G; Di Marco L; Pennisi G; Borghi M; Di Martino V; Filomia R; Abdel-Hadi Y; Crapanzano L; Raimondo G; Lampertico P; Craxì A; Cammà C; Di Marco V
Am J Gastroenterol; 2022 Nov; 117(11):1816-1824. PubMed ID: 35973181
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
Vijayaraghavan R; Jindal A; Arora V; Choudhary A; Kumar G; Sarin SK
Am J Gastroenterol; 2020 May; 115(5):729-737. PubMed ID: 32079861
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive assessment of fibrosis regression and portal hypertension in patients with advanced chronic hepatitis C virus (HCV)-associated liver disease and sustained virologic response (SVR): 3 years follow-up of a prospective longitudinal study.
Knop V; Hoppe D; Vermehren J; Troetschler S; Herrmann E; Vermehren A; Friedrich-Rust M; Sarrazin C; Trebicka J; Zeuzem S; Welker MW
J Viral Hepat; 2021 Nov; 28(11):1604-1613. PubMed ID: 34342081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
